Cytotoxic Chemicals in Chemo Drugs Are Dangerous to Families, Caregivers, and the Environment

Controlling Hazardous Drugs Excreted by the Patient:
How USP 800* will Impact the Cancer Treatment Industry
Knowledge-based home-study CPE activity designed to assist today's pharmacist and pharmacy technician in the advancement of pharmacy practice.

Activity Overview
Cytotoxic chemotherapy drugs are acknowledged as some of the most dangerous chemicals ever created. Industries involved with these chemicals have implemented extreme safety protocols. It is generally accepted that chemotherapy p​patients are unwittingly excreting these chemicals in active form in their urine, feces, and vomit, after every treatment. In December 2019 United States Pharmacopeia (USP) 800 will force the providers of cancer treatments to provide collection systems for the human waste as stated by the Joint Commission, OSHA, and the World Health Organization. This course gives the history of why these regulations were put in place, who is responsible, and how to solve this problem in a safe compliant and cost-effective standard of care. We discuss how patients undergoing life-saving treatments can protect their families, caregivers and the environment from the cytotoxic chemotherapy drugs as they exit the body.

Why Now?

In December 2019 the adoption of United States Pharmacopeia (USP) 800, in conjunction with other existing legal and regulatory standards, will require providers of certain cytotoxic cancer treatments to provide off-site collection systems for waste from patients that may contain hazardous materials or their metabolites in order to ensure that they are properly handled and disposed of in the same manner as the parent compound.

Presented by: Jim Mullowney, President Pharma-Cycle, LLC.
Associate Member American Society of Clinical Oncology
Member of the American Chemical Society

This home study activity was made possible through an educational grant provided by Shepard Medical Products

Learning Objectives

After successfully completing this activity the pharmacist and pharmacy technician will be able to:

  • Explain what Hazardous Drug Human Waste (HDHW) is
  • Identify HDHW contained in Human wasteState current ePA Standards
  • List agencies that regulate HDHW
  • Describe limitations on Malpractice and Product Liability Insurance Policies
  • Describe collection and disposal methods


$10.00 Registration Fee- Pharmacists
$5.00 Registration Fee- Pharmacy Technician

To Register Click Here

  • Create an account on the CPE Consultants, LLC learning management website
  • Under CE Catalog, select the Distance tab
  • Select the activity: Controlling Hazardous Drugs Excreted by the Patient

To receive continuing pharmacy education credit

  • Complete the online post-test (80% or higher pass rate)
  • Complete the online evaluation within 30 days of registering for this activity
  • Return to the home page and select View/Print CE Credit
  • Continuing education credits will be uploaded automatically to CPE Monitor


Accreditation Statement

CPE Consultants, LLC is accredited by the Accreditation Council for Pharmacy Education to provide continuing education for pharmacists and pharmacy technicians.

CPE Consultants, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE).  As an approved provider it is our responsibility to ensure activities are developed and executed in accordance with the ACPE Standards for Continuing Pharmacy Education, effective January 1, 2009.  This includes ensuring each activity is a structured educational activity designed to support the continuing professional development of pharmacists and pharmacy technicians in order to help them maintain and enhance their competence.  An education grant was provided for this activity. 

° UAN: 0864-9999-18-053-H04-P  ° UAN 0864-9999-18-053-H04-T
  ° Release date: July 1,
2018 ° Expiration date: July 1, 2021

Complete accreditation information is available on the CPE Consultants' website:

*Not affiliated with DOT, OSHA, Joint Commission, or USP-800